These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31480747)

  • 21. A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.
    Kueck T; Neil SJ
    PLoS Pathog; 2012; 8(3):e1002609. PubMed ID: 22479182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment.
    Dubé M; Roy BB; Guiot-Guillain P; Binette J; Mercier J; Chiasson A; Cohen EA
    PLoS Pathog; 2010 Apr; 6(4):e1000856. PubMed ID: 20386718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.
    Mitchell RS; Katsura C; Skasko MA; Fitzpatrick K; Lau D; Ruiz A; Stephens EB; Margottin-Goguet F; Benarous R; Guatelli JC
    PLoS Pathog; 2009 May; 5(5):e1000450. PubMed ID: 19478868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2.
    Pham TN; Lukhele S; Hajjar F; Routy JP; Cohen ÉA
    Retrovirology; 2014 Feb; 11():15. PubMed ID: 24498878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.
    Sato K; Misawa N; Fukuhara M; Iwami S; An DS; Ito M; Koyanagi Y
    J Virol; 2012 May; 86(9):5000-13. PubMed ID: 22357275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation.
    Zhang Q; Mi Z; Huang Y; Ma L; Ding J; Wang J; Zhang Y; Chen Y; Zhou J; Guo F; Li X; Cen S
    Retrovirology; 2016 Mar; 13():13. PubMed ID: 26935098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
    Yoshida T; Koyanagi Y; Strebel K
    J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.
    Shi J; Xiong R; Zhou T; Su P; Zhang X; Qiu X; Li H; Li S; Yu C; Wang B; Ding C; Smithgall TE; Zheng YH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Throughput NanoBiT-Based Screening for Inhibitors of HIV-1 Vpu and Host BST-2 Protein Interaction.
    Li B; Dong X; Zhang W; Chen T; Yu B; Zhao W; Yang Y; Wang X; Hu Q; Wang X
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
    Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
    PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of viral protein U (Vpu) with cellular factors.
    Guatelli JC
    Curr Top Microbiol Immunol; 2009; 339():27-45. PubMed ID: 20012522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
    Dubé M; Bego MG; Paquay C; Cohen ÉA
    Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses.
    Lim ES; Malik HS; Emerman M
    J Virol; 2010 Jul; 84(14):7124-34. PubMed ID: 20444900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation.
    Mumby MJ; Johnson AL; Trothen SM; Edgar CR; Gibson R; Stathopulos PB; Arts EJ; Dikeakos JD
    J Virol; 2021 Jul; 95(16):e0058821. PubMed ID: 34037423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.
    Dubé M; Paquay C; Roy BB; Bego MG; Mercier J; Cohen EA
    Traffic; 2011 Dec; 12(12):1714-29. PubMed ID: 21902775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The great escape: viral strategies to counter BST-2/tetherin.
    Douglas JL; Gustin JK; Viswanathan K; Mansouri M; Moses AV; Früh K
    PLoS Pathog; 2010 May; 6(5):e1000913. PubMed ID: 20485522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
    Serra-Moreno R; Zimmermann K; Stern LJ; Evans DT
    PLoS Pathog; 2013; 9(7):e1003487. PubMed ID: 23853598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.